{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:37:47Z","timestamp":1782254267290,"version":"3.54.5"},"reference-count":117,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":65,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lipidjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jacl.2024.09.005","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T14:25:22Z","timestamp":1744295122000},"page":"215-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Managing hypercholesterolemia in adults older than 75 years without a history of atherosclerotic cardiovascular disease: An Expert Clinical Consensus from the National Lipid Association and the American Geriatrics Society"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9456-850X","authenticated-orcid":false,"given":"Vera","family":"Bittner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3271-7407","authenticated-orcid":false,"given":"Sunny A.","family":"Linnebur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7560-9521","authenticated-orcid":false,"given":"Dave L.","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Forman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel R.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9926-2179","authenticated-orcid":false,"given":"Terry A.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4297-6306","authenticated-orcid":false,"given":"Ariela R.","family":"Orkaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0341-5140","authenticated-orcid":false,"given":"Joseph J.","family":"Saseen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9541-6954","authenticated-orcid":false,"given":"Salim S.","family":"Virani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2024.09.005_bib0001","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.jacc.2019.02.012","article-title":"Recent Innovations, Modifications, and Evolution of ACC\/AHA Clinical Practice Guidelines: An Update for Our Constituencies: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Levine","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.09.005_bib0002","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/CIR.0b013e31827e8e5f","article-title":"ACCF\/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"Jacobs","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2024.09.005_bib0003","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.pcad.2014.03.005","article-title":"Lipid-lowering therapy in patients 75 years and older: clinical priority or superfluous therapy?","volume":"57","author":"Phan","year":"2014","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jacl.2024.09.005_bib0004","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0140-6736(01)05553-2","article-title":"Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study","volume":"358","author":"Schatz","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2024.09.005_bib0005","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-126-10-199705150-00001","article-title":"Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons","volume":"126","author":"Corti","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacl.2024.09.005_bib0006","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(20)32233-9","article-title":"Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70-100 years: a contemporary primary prevention cohort","volume":"396","author":"Mortensen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2024.09.005_bib0007","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(07)61778-4","article-title":"Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths","volume":"370","author":"Collaboration","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2024.09.005_bib0008","doi-asserted-by":"crossref","first-page":"e1162","DOI":"10.1161\/CIR.0000000000000638","article-title":"Use of Risk assessment tools to guide decision-making in the primary prevention of atherosclerotic cardiovascular disease: a special report from the American heart association and American college of cardiology","volume":"139","author":"Lloyd-Jones","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2024.09.005_bib0009","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11883-019-0776-8","article-title":"2018 Cholesterol Guidelines: Key Topics in Primary Prevention","volume":"21","author":"Clark","year":"2019","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacl.2024.09.005_bib0010","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1093\/eurheartj\/ehab312","article-title":"SCORE2-OP working group and ESC Cardiovascular risk collaboration. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions","volume":"42","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2024.09.005_bib0011","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Goff","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.09.005_bib0012","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/jama.297.6.611","article-title":"Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score","volume":"297","author":"Ridker","year":"2007","journal-title":"Jama"},{"key":"10.1016\/j.jacl.2024.09.005_bib0013","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/CIRCULATIONAHA.108.814251","article-title":"Cook NR. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men","volume":"118","author":"Ridker","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2024.09.005_bib0014","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2024.09.005_bib0015","article-title":"Life's Essential 8: Optimizing Health in Older Adults","volume":"2","author":"Kumar","year":"2023","journal-title":"JACC Adv"},{"key":"10.1016\/j.jacl.2024.09.005_bib0016","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and Validation of the American Heart Association's PREVENT Equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2024.09.005_bib0017","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1177\/2047487317693949","article-title":"NORRISK 2: A Norwegian risk model for acute cerebral stroke and myocardial infarction","volume":"24","author":"Selmer","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacl.2024.09.005_bib0018","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00392-016-1023-8","article-title":"Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients","volume":"106","author":"Stam-Slob","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacl.2024.09.005_bib0019","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s11606-011-1725-6","article-title":"Change in comorbidity prevalence with advancing age among persons with heart failure","volume":"26","author":"Ahluwalia","year":"2011","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jacl.2024.09.005_bib0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.7326\/0003-4819-157-6-201209180-00002","article-title":"Development and validation of a coronary risk prediction model for older U.S. and European persons in the Cardiovascular Health Study and the Rotterdam Study","volume":"157","author":"Koller","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacl.2024.09.005_bib0021","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1093\/eurheartj\/ehy217","article-title":"Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA)","volume":"39","author":"Budoff","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2024.09.005_bib0022","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1093\/eurheartj\/ehs230","article-title":"Coronary artery calcium for the prediction of mortality in young adults <45 years old and elderly adults >75 years old","volume":"33","author":"Tota-Maharaj","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2024.09.005_bib0023","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jacc.2010.06.029","article-title":"Coronary calcium score improves classification of coronary heart disease risk in the elderly: the Rotterdam study","volume":"56","author":"Elias-Smale","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.09.005_bib0024","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jacc.2016.05.084","article-title":"A Simple Disease-Guided Approach to Personalize ACC\/AHA-Recommended Statin Allocation in Elderly People: The BioImage Study","volume":"68","author":"Mortensen","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.09.005_bib0025","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.015026","article-title":"Coronary artery calcification and one-year cardiovascular disease incidence in the 75-and-Older Population: The ARIC Study","volume":"16","author":"Mok","year":"2023","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacl.2024.09.005_bib0026","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.atherosclerosis.2014.02.017","article-title":"Comparing coronary artery calcium among U.S. South Asians with four racial\/ethnic groups: the MASALA and MESA studies","volume":"234","author":"Kanaya","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2024.09.005_bib0027","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1161\/CIRCULATIONAHA.121.056705","article-title":"Determinants of incident atherosclerotic cardiovascular disease events among those with absent coronary artery calcium: multi-ethnic study of atherosclerosis","volume":"145","author":"Al Rifai","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2024.09.005_bib0028","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jacl.2020.12.005","article-title":"The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction","volume":"15","author":"Orringer","year":"2021","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2024.09.005_bib0029","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jacc.2015.08.035","volume":"66","author":"McClelland","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.09.005_bib0030","doi-asserted-by":"crossref","first-page":"j2099","DOI":"10.1136\/bmj.j2099","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study","volume":"357","author":"Hippisley-Cox","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jacl.2024.09.005_bib0031","first-page":"e1046","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2024.09.005_bib0032","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.7326\/M22-2643","article-title":"Association between age and low-density lipoprotein cholesterol response to statins: a danish nationwide cohort study","volume":"176","author":"Corn","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacl.2024.09.005_bib0033","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.jacc.2023.07.027","article-title":"LDL-C reduction with lipid-lowering therapy for primary prevention of major vascular events among older individuals","volume":"82","author":"Andersson","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.09.005_bib0034","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jamainternmed.2020.6084","article-title":"Evaluation of time to benefit of statins for the primary prevention of cardiovascular events in adults aged 50 to 75 years: a meta-analysis","volume":"181","author":"Yourman","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacl.2024.09.005_bib0035","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(18)31942-1","article-title":"Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials","volume":"393","author":"Collaboration","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2024.09.005_bib0036","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/CIR.0000000000000380","article-title":"Knowledge gaps in cardiovascular care of the older adult population: a scientific statement from the american heart association, american college of cardiology, and American geriatrics society","volume":"133","author":"Rich","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2024.09.005_bib0037","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"Heart Protection Study Collaborative Group. MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2024.09.005_bib0038","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2024.09.005_bib0039","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2024.09.005_bib0040","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMoa1600176","article-title":"Cholesterol lowering in intermediate-risk persons without cardiovascular disease","volume":"374","author":"Yusuf","year":"2016","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jacl.2024.09.005_bib0041","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/jamainternmed.2017.1442","article-title":"Effect of statin treatment vs usual care on primary cardiovascular prevention among older adults: The ALLHAT-LLT Randomized Clinical Trial","volume":"177","author":"Han","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacl.2024.09.005_bib0042","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/CIRCULATIONAHA.117.028271","article-title":"primary prevention with statin therapy in the elderly: new meta-analyses from the contemporary JUPITER and HOPE-3 Randomized Trials","volume":"135","author":"Ridker","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2024.09.005_bib0043","doi-asserted-by":"crossref","DOI":"10.7326\/M24-0004","article-title":"Benefits and risks associated with statin therapy for primary prevention in old and very old adults: real-world evidence from a target trial emulation study","author":"Xu","year":"2024","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacl.2024.09.005_bib0044","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-069915","article-title":"Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial)","volume":"13","author":"Zoungas","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacl.2024.09.005_bib0045","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/jgs.18312","article-title":"Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationale","volume":"71","author":"Joseph","year":"2023","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jacl.2024.09.005_bib0046","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1001\/jama.288.23.2998","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2024.09.005_bib0047","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/HJH.0b013e328342c8f7","article-title":"Impact of atorvastatin among older and younger patients in the Anglo-Scandinavian Cardiac Outcomes Trial Lipid-Lowering Arm","volume":"29","author":"Collier","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacl.2024.09.005_bib0048","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jacl.2024.09.005_bib0049","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0140-6736(22)01545-8","article-title":"Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials","volume":"400","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2024.09.005_bib0050","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008546","article-title":"Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry","volume":"7","author":"Nanna","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacl.2024.09.005_bib0051","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2024.09.005_bib0052","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(12)61190-8","article-title":"Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial","volume":"380","author":"Ridker","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2024.09.005_bib0053","first-page":"306","article-title":"Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis","year":"2024","journal-title":"Lancet Diab Endocrinol"},{"key":"10.1016\/j.jacl.2024.09.005_bib0054","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jacl.2020.12.011","article-title":"Statins, lipids and dementia?","volume":"15","author":"Kuller","year":"2021","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2024.09.005_bib0055","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1016\/j.jacc.2021.04.075","article-title":"Effect of Statin Therapy on Cognitive Decline and Incident Dementia in Older Adults","volume":"77","author":"Zhou","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.09.005_bib0056","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jacl.2020.10.007","article-title":"Association between statin use and cognitive function: A systematic review of randomized clinical trials and observational studies","volume":"15","author":"Adhikari","year":"2021","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2024.09.005_bib0057","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.jacc.2019.09.041","article-title":"Effects of Statins on Memory, Cognition, and Brain Volume in the Elderly","volume":"74","author":"Samaras","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.09.005_bib0058","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jacc.2021.07.022","article-title":"Side Effect Patterns in a Crossover Trial of Statin, Placebo, and No Treatment","volume":"78","author":"Howard","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.09.005_bib0059","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jacl.2022.05.068","article-title":"NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient","volume":"16","author":"Cheeley","year":"2022","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2024.09.005_bib0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jacl.2022.09.001","article-title":"Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association","volume":"17","author":"Warden","year":"2023","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2024.09.005_bib0061","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009217.pub2","article-title":"Statins for the primary prevention of cardiovascular disease","volume":"2013","author":"Taylor","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacl.2024.09.005_bib0062","doi-asserted-by":"crossref","first-page":"e3310","DOI":"10.1002\/dmrr.3310","article-title":"Statins are associated with new onset type 2 diabetes mellitus (T2DM) in Medicare patients >\/=65 years","volume":"36","author":"Tangelloju","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jacl.2024.09.005_bib0063","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s00125-014-3383-9","article-title":"Contrasting associations of insulin resistance with diabetes, cardiovascular disease and all-cause mortality in the elderly: PROSPER long-term follow-up","volume":"57","author":"Welsh","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.jacl.2024.09.005_bib0064","doi-asserted-by":"crossref","first-page":"e1435","DOI":"10.1212\/WNL.0000000000007174","article-title":"Effects of blood pressure and lipid lowering on cognition: Results from the HOPE-3 study","volume":"92","author":"Bosch","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.jacl.2024.09.005_bib0065","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00415-009-5271-7","article-title":"Pravastatin and cognitive function in the elderly. Results of the PROSPER study","volume":"257","author":"Trompet","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.jacl.2024.09.005_bib0066","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.trci.2017.01.001","article-title":"Alzheimer's Disease Neuroimaging Initiative. The Effect of Statins on Rate of Cognitive Decline in Mild Cognitive Impairment","volume":"3","author":"Smith","year":"2017","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.jacl.2024.09.005_bib0067","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1001\/jama.285.21.2750","article-title":"Cancer screening in elderly patients: a framework for individualized decision making","volume":"285","author":"Walter","year":"2001","journal-title":"Jama"},{"key":"10.1016\/j.jacl.2024.09.005_bib0068","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/j.1532-5415.2012.04054.x","article-title":"Oude Voshaar RC. Prevalence of frailty in community-dwelling older persons: a systematic review","volume":"60","author":"Collard","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jacl.2024.09.005_bib0069","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jamda.2015.06.025","article-title":"Prevalence of Frailty in Nursing Homes: A Systematic Review and Meta-Analysis","volume":"16","author":"Kojima","year":"2015","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jacl.2024.09.005_bib0070","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/alz.12638","article-title":"2022 Alzheimer's disease facts and figures","volume":"18","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jacl.2024.09.005_bib0071","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/jgs.17468","article-title":"Life expectancy estimates based on comorbidities and frailty to inform preventive care","volume":"70","author":"Schoenborn","year":"2022","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jacl.2024.09.005_bib0072","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1001\/jama.2013.282612","article-title":"Incorporating lag time to benefit into prevention decisions for older adults","volume":"310","author":"Lee","year":"2013","journal-title":"Jama"},{"key":"10.1016\/j.jacl.2024.09.005_bib0073","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/jgs.18190","article-title":"Operationalizing deprescribing as a component of goal-concordant dementia care","volume":"71","author":"Niznik","year":"2023","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jacl.2024.09.005_bib0074","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s11606-014-3074-8","article-title":"Navigating the unknown: shared decision-making in the face of uncertainty","volume":"30","author":"Berger","year":"2015","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jacl.2024.09.005_bib0075","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1532-5415.2009.02497.x","article-title":"The vulnerable elders-13 survey predicts 5-year functional decline and mortality outcomes in older ambulatory care patients","volume":"57","author":"Min","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jacl.2024.09.005_bib0076","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2019.08.001","article-title":"Walking pace is inversely associated with risk of death and cardiovascular disease: The Physicians' Health Study","volume":"289","author":"Imran","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2024.09.005_bib0077","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1093\/eurheartj\/ehab468","article-title":"Frailty and cardiovascular outcomes in the National Health and Aging Trends Study","volume":"42","author":"Damluji","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2024.09.005_bib0078","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1093\/eurheartj\/ehab481","article-title":"Moving beyond chronological age: frailty as an important risk factor for cardiovascular disease","volume":"42","author":"Orkaby","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2024.09.005_bib0079","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/bcp.13590","article-title":"The relationship between frailty and polypharmacy in older people: A systematic review","volume":"84","author":"Gutierrez-Valencia","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacl.2024.09.005_bib0080","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/jgs.18700","article-title":"New statin use, mortality, and first cardiovascular events in older US Veterans by frailty status","volume":"72","author":"Orkaby","year":"2024","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jacl.2024.09.005_bib0081","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A global clinical measure of fitness and frailty in elderly people","volume":"173","author":"Rockwood","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.jacl.2024.09.005_bib0082","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1056\/NEJMvcm2009406","article-title":"Mobility Assessment in Older Adults","volume":"385","author":"James","year":"2021","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jacl.2024.09.005_bib0083","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","article-title":"Up & Go\": a test of basic functional mobility for frail elderly persons","volume":"39","author":"Podsiadlo","year":"1991","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jacl.2024.09.005_bib0084","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ageing\/32.3.315","article-title":"Identifying a cut-off point for normal mobility: a comparison of the timed 'up and go' test in community-dwelling and institutionalised elderly women","volume":"32","author":"Bischoff","year":"2003","journal-title":"Age Ageing"},{"key":"10.1016\/j.jacl.2024.09.005_bib0085","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1046\/j.1532-5415.2003.51465.x","article-title":"The Mini-Cog as a screen for dementia: validation in a population-based sample","volume":"51","author":"Borson","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jacl.2024.09.005_bib0086","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1111\/jgs.18453","article-title":"A crosswalk of commonly used frailty scales","volume":"71","author":"Sison","year":"2023","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jacl.2024.09.005_bib0087","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2318-8-24","article-title":"A standard procedure for creating a frailty index","volume":"8","author":"Searle","year":"2008","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jacl.2024.09.005_bib0088","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-152-8-201004200-00005","article-title":"Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial","volume":"152","author":"Glynn","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacl.2024.09.005_bib0089","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001233","article-title":"Patient-centered adult cardiovascular care: a scientific statement from the American heart association","author":"Goldfarb","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2024.09.005_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000134","article-title":"The effect of alternative summary statistics for communicating risk reduction on decisions about taking statins: a randomized trial","volume":"6","author":"Carling","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.jacl.2024.09.005_bib0091","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1177\/0272989X09333120","article-title":"Should clinicians deliver decision aids? further exploration of the statin choice randomized trial results","volume":"29","author":"Jones","year":"2009","journal-title":"Med Decision Making"},{"key":"10.1016\/j.jacl.2024.09.005_bib0092","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.pec.2009.10.008","article-title":"The Statin Choice decision aid in primary care: a randomized trial","volume":"80","author":"Mann","year":"2010","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.jacl.2024.09.005_bib0093","doi-asserted-by":"crossref","first-page":"e3693","DOI":"10.1371\/journal.pone.0003693","article-title":"How should the impact of different presentations of treatment effects on patient choice be evaluated? A pilot randomized trial","volume":"3","author":"Carling","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jacl.2024.09.005_bib0094","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1001\/archinte.167.10.1076","article-title":"Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial","volume":"167","author":"Weymiller","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacl.2024.09.005_bib0095","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/1472-6963-13-301","article-title":"Shared decision making for patients with type 2 diabetes: a randomized trial in primary care","volume":"13","author":"Branda","year":"2013","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jacl.2024.09.005_bib0096","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.pec.2010.04.032","article-title":"Health outcome prioritization to elicit preferences of older persons with multiple health conditions","volume":"83","author":"Fried","year":"2011","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.jacl.2024.09.005_bib0097","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1001\/archinternmed.2011.424","article-title":"Health outcome prioritization as a tool for decision making among older persons with multiple chronic conditions","volume":"171","author":"Fried","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacl.2024.09.005_bib0098","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/jgs.16371","article-title":"Chronic disease decision making and \"what matters most\"","volume":"68","author":"Fried","year":"2020","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jacl.2024.09.005_bib0099","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s11096-015-0148-6","article-title":"Recommendations to support deprescribing medications late in life","volume":"37","author":"Todd","year":"2015","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.jacl.2024.09.005_bib0100","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1093\/eurheartj\/ehz458","article-title":"Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France","volume":"40","author":"Giral","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2024.09.005_bib0101","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.36802","article-title":"Statin discontinuation and cardiovascular events among older people in Denmark","volume":"4","author":"Thompson","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacl.2024.09.005_bib0102","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.13186","article-title":"Cardiovascular outcomes and mortality associated with discontinuing statins in older patients receiving polypharmacy","volume":"4","author":"Rea","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacl.2024.09.005_bib0103","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jamainternmed.2015.0289","article-title":"Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial","volume":"175","author":"Kutner","year":"2015","journal-title":"JAMA internal medicine"},{"key":"10.1016\/j.jacl.2024.09.005_bib0104","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s11096-015-0147-7","article-title":"Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia","volume":"37","author":"Qi","year":"2015","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.jacl.2024.09.005_bib0105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/fampra\/cmab075","article-title":"GP preferences for discussing statin deprescribing: a discrete choice experiment","volume":"39","author":"Thompson","year":"2022","journal-title":"Fam Pract"},{"key":"10.1016\/j.jacl.2024.09.005_bib0106","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.2633","article-title":"Assessment of patient-preferred language to achieve goal-aligned deprescribing in older adults","volume":"4","author":"Green","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacl.2024.09.005_bib0107","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/jama.287.5.622","article-title":"Nonspecific medication side effects and the nocebo phenomenon","volume":"287","author":"Barsky","year":"2002","journal-title":"Jama"},{"key":"10.1016\/j.jacl.2024.09.005_bib0108","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1007\/s11606-020-06063-y","article-title":"Designing a primary care-based deprescribing intervention for patients with dementia and multiple chronic conditions: a qualitative study","volume":"35","author":"Green","year":"2020","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jacl.2024.09.005_bib0109","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/jamacardio.2019.2604","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: part 1, lifestyle and behavioral factors","volume":"4","author":"Arnett","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacl.2024.09.005_bib0110","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2024.09.005_bib0111","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2024.09.005_bib0112","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/CIRCULATIONAHA.118.039415","article-title":"Ezetimibe lipid-lowering trial on prevention of atherosclerotic cardiovascular disease in 75 or older (ewtopia 75): a randomized, controlled trial","volume":"140","author":"Ouchi","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2024.09.005_bib0113","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","article-title":"Bempedoic acid and cardiovascular outcomes in statin-intolerant patients","volume":"388","author":"Nissen","year":"2023","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.jacl.2024.09.005_bib0114","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1093\/eurheartj\/ehz809","article-title":"Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis","volume":"41","author":"Sinnaeve","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2024.09.005_bib0115","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1177\/2047487320902750","article-title":"LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial","volume":"28","author":"Sever","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacl.2024.09.005_bib0116","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/jama.2023.9696","article-title":"Bempedoic Acid for primary prevention of cardiovascular events in statin-intolerant patients","volume":"330","author":"Nissen","year":"2023","journal-title":"Jama"},{"key":"10.1016\/j.jacl.2024.09.005_bib0117","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s13063-020-04259-5","article-title":"Discontinuing statins or not in the elderly? Study protocol for a randomized controlled trial","volume":"21","author":"Bonnet","year":"2020","journal-title":"Trials"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287424002459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287424002459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T16:45:31Z","timestamp":1746463531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287424002459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":117,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1933287424002459"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2024.09.005","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Managing hypercholesterolemia in adults older than 75 years without a history of atherosclerotic cardiovascular disease: An Expert Clinical Consensus from the National Lipid Association and the American Geriatrics Society","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2024.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Dr. Vera A. Bittner. Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}